LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

39.22 1.27

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

38.06

Max

39.23

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	12.278 80.03
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	14M 73M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+18.19% upside

Turustatistika
By TradingEconomics
Turukapital	554M 2.2B
Eelmine avamishind	37.95
Eelmine sulgemishind	39.22

Uudiste sentiment

By Acuity

50%

182 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. dets 2025, 22:13 UTC

Tulu

GE Vernova Raises Outlook, Doubles Dividend on Energy Market Momentum

9. dets 2025, 21:40 UTC

Tulu

GameStop Sales Fall as Collectibles Remain Only Bright Spot

9. dets 2025, 18:51 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9. dets 2025, 16:57 UTC

Suurimad hinnamuutused turgudel

Clear Secure Rises on Medicare Identity Verification Contract

9. dets 2025, 23:46 UTC

Market Talk

Nikkei May Trade Rangebound Ahead of Fed Rate Decision -- Market Talk

9. dets 2025, 23:46 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings Stake in Lenovo Now at 32.34%

9. dets 2025, 23:45 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Remains Optimistic About Lenovo's Future Development Potential

9. dets 2025, 23:44 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Purchased Lenovo Shares at Average Price of HK$9.7653/Share

9. dets 2025, 23:43 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Acquired Lenovo Shares for Total Cash Consideration of HK$1.12B

9. dets 2025, 23:43 UTC

Omandamised, ülevõtmised, äriostud

Legend Holdings: Acquired 115.17M Lenovo Shares From Open Market Between Nov. 21 and Dec. 9

9. dets 2025, 23:35 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

9. dets 2025, 22:42 UTC

Tulu

PepsiCo Wants to Boost Sales, Cut Costs. The Street Is Doubtful. -- Barrons.com

9. dets 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. dets 2025, 21:48 UTC

Market Talk

Hiring Confidence Slips in Canada Entering 2026 -- Market Talk

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Fiscal 2026 EBITDA Is Expected to Increase 15% to 17% >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Total Inside Gross Profit Increased 13.5% to $703.4M Compared to Prior Yr >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Now Expects Inside Same-Store Sales to Increase 3% to 4% and an Inside Margin of 41% to 42% >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Same-Store Fuel Gallons Up 0.8% Compared to Prior Yr With Fuel Margin of 41.6 Cents per Gallon, Total Fuel Gross Profit Increased 20.9% to $377.4M Compared to Prior Yr >CASY

9. dets 2025, 21:36 UTC

Tulu

Casey's General Stores: Inside Same-Store Sales Increased 3.3% Compared to Prior Yr, and 7.5% on 2-Yr Stack Basis, With an Inside Margin of 42.4% >CASY

9. dets 2025, 20:28 UTC

Market Talk

Oil Futures Decline for Second Straight Session -- Market Talk

9. dets 2025, 20:27 UTC

Omandamised, ülevõtmised, äriostud

Teck Resources: Merger of Equals With Anglo Amer Plc Approved by Both Classes of Teck Hldrs

9. dets 2025, 20:27 UTC

Omandamised, ülevõtmised, äriostud

Teck Reports Voting Results From Special Meeting of Hldrs

9. dets 2025, 20:26 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Moody's: Paramount's Warner Bid Makes Strategic Sense, With Risk -- Market Talk

9. dets 2025, 20:21 UTC

Market Talk

U.S. Natural Gas Extends Pullback on Shifting Weather Outlook -- Market Talk

9. dets 2025, 19:52 UTC

Tulu

Correction to 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com on Dec. 8

9. dets 2025, 19:17 UTC

Tulu

Update: 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com

9. dets 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. dets 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. dets 2025, 17:11 UTC

Tulu

Nvidia Has Permission to Sell H200 Chips to China. Why It Might Not Matter Much for the Stock. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

18.19% tõus

12 kuu keskmine prognoos

Keskmine 46 USD 18.19%

Kõrge 62 USD

Madal 32 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

Osta

Hoia

Müü

Põhineb 10 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

182 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.